封面
市场调查报告书
商品编码
1481285

医学影像分析软体市场规模- 按软体类型(整合、独立)、模式(断层扫描、超音波、放射线照相)、影像类型、应用(骨科、牙科、神经病学、心臟病学)、最终用户和预测,2024 - 2032

Medical Image Analysis Software Market Size - By Software Type (Integrated, Standalone), Modality (Tomography, Ultrasound, Radiographic), Imaging Type, Application (Orthopedics, Dental, Neurology, Cardiology), End-user & Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 190 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于人工智慧在全球的日益普及,医学影像分析软体市场规模预计在 2024 年至 2032 年间以 7% 的复合年增长率增长。影像分析软体中的人工智慧演算法有助于提高诊断准确性、自动化影像解释并实现高效的资料分析。例如,2023 年12 月,GE HealthCare 推出了一款新的人工智慧MRI 系统,该系统具有高效能,能够达到患者舒适度的基准,并突出当前人工智慧和深度学习驱动的技术,以协助更快、更精确的扫描。医疗保健提供者正在利用此类人工智慧驱动的软体进行 MRI、CT 和超音波等先进影像模式,以改善疾病检测和治疗计划。人工智慧检测细微异常、预测疾病进展和协助个人化医疗的能力正在推动市场成长。

医学影像分析软体产业分为软体类型、模式、影像类型、应用程式、最终用户和区域。

根据软体类型,由于其灵活性和易用性,独立细分市场的市场规模预计从2024 年到2032 年将实现7.3% 的复合年增长率,使医疗保健专业人员能够在不依赖额外平台或系统的情况下分析医学影像。医疗机构越来越多地采用独立影像分析软体,因为它在各种成像模式(例如 MRI、CT 和 X 光)中具有多功能性。此外,基于人工智慧的图像解释和 3D 视觉化等软体功能的进步将推动该细分市场的成长。

在应用方面,神经病学领域的医学影像分析软体市场预计在2024年至2032年间将成长7.5%。 、阿兹海默症和中风。专注于神经病学的软体提供了专门的工具,用于准确的大脑绘图、病变检测和大脑结构的定量分析。神经系统疾病盛行率的上升以及对精确诊断工具的需求不断增加也将推动该细分市场的扩张。

从地区来看,由于该地区医疗保健基础设施的不断发展以及对先进医学成像技术的需求不断增长,亚太地区医学影像分析软体市场预计在 2024 年至 2032 年间呈现 7.2% 的复合年增长率。中国、日本和印度等主要国家正大力投资医疗保健 IT 解决方案,推动影像分析软体的采用。慢性病的日益普及和人口老化进一步增加了对准确诊断工具的需求。此外,一些公司和政府正在采取措施促进医疗保健数位化,并推动基于人工智慧的解决方案在该地区的采用。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病发生率不断上升
      • 全球老年人口数量不断增加
      • 快速结果验证和增强诊断能力的需求增加
      • 对非侵入性诊断解决方案的需求不断扩大
      • 人们对远距医疗和远距医疗保健服务的兴趣日益浓厚
      • 成像方法不断进步
    • 产业陷阱与挑战
      • 整合复杂度
      • 资料安全和隐私问题
  • 成长潜力分析
  • 监管环境
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按软体类型,2018 年 - 2032 年

  • 主要趋势
  • 融合的
  • 独立式

第 6 章:市场估计与预测:按模式,2018 - 2032 年

  • 主要趋势
  • 断层扫描
    • CT检查
      • 高切片
      • 中片
      • 低切片
      • 锥束
    • 磁振造影
      • 开放系统
      • 封闭系统
    • 正子断层扫描
    • 单光子发射断层扫描
  • 超音波成像
    • QR 图
    • 3D & 4D
    • 多普勒
  • 射线照相成像
  • 组合方式
    • 正电子发射/磁共振
    • SPECT/CT
    • 正子断层扫描/CT

第 7 章:市场估计与预测:按影像类型,2018 年 - 2032 年

  • 主要趋势
  • QR 图
  • 3D
  • 4D

第 8 章:市场估计与预测:按应用划分,2018 年 - 2032 年

  • 主要趋势
  • 骨科
  • 牙科
  • 神经病学
  • 心臟病学
  • 肿瘤学
  • 妇产科
  • 乳房X光检查
  • 呼吸系统
  • 其他应用

第 9 章:市场估计与预测:按最终用户划分,2018 年 - 2032 年

  • 主要趋势
  • 医院
  • 诊断中心
  • 门诊手术中心
  • 其他最终用户

第 10 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要动向:按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 11 章:公司简介

  • Aidoc
  • CardioComm Solutions Inc.
  • Canon Medical Systems USA
  • eMedica, S.
  • Esaote SPA
  • Evident
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.,
  • Leica Microsystems
  • Medis Medical Imaging Systems
  • Siemens Healthineers AG
  • Spacelabs Healthcare
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: 8363

Medical Image Analysis Software Market size is poised to grow at 7% CAGR between 2024 and 2032, attributed to the growing adoption of AI worldwide. AI algorithms in image analysis software help enhance diagnostic accuracy, automate image interpretation, and enable efficient data analysis. For instance, in December 2023, GE HealthCare launched a new AI-enabled MRI system for enabling high performance to bore the benchmark for patient comfort and highlight current AI and deep learning-driven technologies to assist quicker and more precise scans. Healthcare providers are leveraging such AI-powered software for advanced imaging modalities like MRI, CT, and ultrasound to improve disease detection and treatment planning. The ability of AI to detect subtle abnormalities, predict disease progression, and assist in personalized medicine is driving the market growth.

The medical image analysis software industry is segmented into software type, modality, imaging type, application, end-user, and region.

Based on software type, the market size from the standalone segment is anticipated to attain 7.3% CAGR from 2024-2032 owing to its flexibility and ease of use, allowing healthcare professionals to analyze medical images without relying on additional platforms or systems. Healthcare facilities are increasingly adopting standalone image analysis software for its versatility in various imaging modalities, such as MRI, CT, and X-ray. Additionally, advancements in software capabilities, such as AI-based image interpretation and 3D visualization will propel the segment growth.

In terms of application, the medical image analysis software market from the neurology segment is projected to witness 7.5% growth rate between 2024 and 2032. Advanced image analysis software plays a crucial role in the diagnosis and treatment planning of neurological disorders, such as brain tumors, Alzheimer's disease, and stroke. Neurology-focused software offers specialized tools for accurate brain mapping, lesion detection, and quantitative analysis of brain structures. The rising prevalence of neurological conditions and the increasing demand for precise diagnostic tools will also fuel the segment expansion.

Regionally, the Asia Pacific medical image analysis software market is set to exhibit 7.2% CAGR between 2024 and 2032 driven by the increasing healthcare infrastructure development and the rising demand for advanced medical imaging technologies across the region. Major countries like China, Japan, and India are investing heavily in healthcare IT solutions, driving the adoption of image analysis software. The growing prevalence of chronic diseases and the aging population are further boosting the demand for accurate diagnostic tools. Additionally, several companies and governments are taking initiatives to promote digitization in healthcare and drive the adoption of AI-based solutions in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data validation
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Escalating rates of chronic illnesses
      • 3.2.1.2 Rising numbers of geriatric population worldwide
      • 3.2.1.3 Increased demand for expedited result validation and enhanced diagnostic capabilities
      • 3.2.1.4 Expanding requests for non-invasive diagnostic solutions
      • 3.2.1.5 Increasing interest in telemedicine and remote healthcare provisions
      • 3.2.1.6 Growing advancement in imaging methodologies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Integration complexity
      • 3.2.2.2 Data security and privacy concerns
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Software Type, 2018 - 2032 ($ Million)

  • 5.1 Key trends
  • 5.2 Integrated
  • 5.3 Standalone

Chapter 6 Market Estimates and Forecast, By Modality, 2018 - 2032 ($ Million)

  • 6.1 Key trends
  • 6.2 Tomography
    • 6.2.1 Computed tomography
      • 6.2.1.1 High-slice
      • 6.2.1.2 Mid-slice
      • 6.2.1.3 Low-slice
      • 6.2.1.4 Cone beam
    • 6.2.2 Magnetic resonance imaging
      • 6.2.2.1 Open system
      • 6.2.2.2 Closed system
    • 6.2.3 Positron emission tomography
    • 6.2.4 Single-photon emission tomography
  • 6.3 Ultrasound imaging
    • 6.3.1 2D
    • 6.3.2 3D & 4D
    • 6.3.3 Doppler
  • 6.4 Radiographic imaging
  • 6.5 Combined modalities
    • 6.5.1 PET/MR
    • 6.5.2 SPECT/CT
    • 6.5.3 PET/CT

Chapter 7 Market Estimates and Forecast, By Imaging Type, 2018 - 2032 ($ Million)

  • 7.1 Key trends
  • 7.2 2D
  • 7.3 3D
  • 7.4 4D

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

  • 8.1 Key trends
  • 8.2 Orthopedic
  • 8.3 Dental
  • 8.4 Neurology
  • 8.5 Cardiology
  • 8.6 Oncology
  • 8.7 Obstetrics & gynecology
  • 8.8 Mammography
  • 8.9 Respiratory
  • 8.10 Other applications

Chapter 9 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Diagnostic centers
  • 9.4 Ambulatory surgical centers
  • 9.5 Other end-users

Chapter 10 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

  • 10.1 Key trends, by region
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 Aidoc
  • 11.2 CardioComm Solutions Inc.
  • 11.3 Canon Medical Systems USA
  • 11.4 eMedica, S.
  • 11.5 Esaote SPA
  • 11.6 Evident
  • 11.7 GE HealthCare Technologies, Inc.
  • 11.8 Koninklijke Philips N.V.,
  • 11.9 Leica Microsystems
  • 11.10 Medis Medical Imaging Systems
  • 11.11 Siemens Healthineers AG
  • 11.12 Spacelabs Healthcare
  • 11.13 Thermo Fisher Scientific Inc.